---
title: Klick Wire
---

63% of pharma ok with ads next to news

                                                           

|    Sign Up Today   View in Browser  Issue 698 January 19   53% of MedTech Into AI 93% Expect Requested Tests 85% Say AI Makes Them Better 79% Use Paid Social TV Spend Influence 60% Say News is Better     |
| --- |

|     Industry 53% of MedTech investing in AI-enabled platforms Source: Deloitte Deloitte's life sciences outlook for 2026 is based on a survey of 140 US and 140 ex-US industry leaders. These groups had relatively stable positive revenue growth expectations (84% and 78%, respectively) but industry performance optimism varied Ex-US More Optimistic in General   Respondents were asked "What is your performance outlook in 2026 for the life sciences industry?" For this general question, the global respondents were much more positive than the US ones. Chart created from data in Deloitte source   Digital & AI Second Only to Regulatory Change   New questions for 2026 included government and regulatory challenges. New National Regulations topped the impact list at 51% "significant impact." Digital and AI was close behind though with 48% saying "significant impact" for digital transformation. Image adapted for email from Deloitte source   GenAI went from 34% in 2025 to 41% in 2026 indicating that the technology is just getting started transforming biotech and medtech. AI is Top Tactic for MedTech   When asked how they were handling "cost management" biotech said R&D while MedTech said AI. Image adapted for email from Deloitte source   When asked how they were planning for growth, biotech said new launches while MedTech said AI platforms. Image adapted for email from Deloitte source   Medical device manufacturers are looking to add AI into their products and use the technology throughout the companies. See the Deloitte report for the full analysis. — Read the full story from Deloitte         MedTech 93% of patients expect tests ordered on request Source: Siemens Healthineers First, the good news. 98% of patients in the US believe that lab tests provide insightful information about their health. Second, though, is that they are pretty demanding. 93% expect their doctor to order a test on request. A small but obstinate group of 13% would disagree with their doctor if told a test wasn't necessary. In this environment it's no wonder that 84% of doctors say they have ordered tests simply to satisfy a patient's request. Siemens worked with YouGov to survey 1,000 Americans who had taken a blood test in the past two years. This biases the data so it cannot be interpreted as all Americans. A Growing Number of Requests are Sparked By Social   A substantial number of patients say they learn about tests from social media. 44% for Millennials makes them the top group, they are also the top group for learning from other sources. Chart created from data in Siemens source, original has numbers stacked but we feel they are not mutually exclusive and should be side-by-side   Most Patients Will Disclose if Health Info From Social   Here we see that Millennials are not just the most likely to take health information from social, they are the most open of the fact. 86% of them would tell their doctor if the piece of health information they were sharing came from social media. Image adapted for email from Siemens Healthineers source   Lab Tests Are Held in High Regard   Tests are an important part of the patient journey and they are trusted by respondents. 98% believe laboratory testing provides insightful information about their health 96% trust lab tests to provide accurate results 95% trust their providers to order the most appropriate tests 94% would be more likely to follow a doctor’s recommendation if it’s supported by lab test results 78% feel they generally understand test results without help from a healthcare provider   — Read the full story from Siemens Healthineers         GenAI in Healthcare 85% clinicians say AI makes them faster and better Source: Bloomberg This story from Bloomberg is about Anthropic's announcement of it's AI product, Claude, expanding into healthcare one week after OpenAI's announcement. Image adapted for email from Bloomberg source   NBC News reports that Anthropic has beat OpenAI to actual usage, even if they announced later: Claude’s new health records functions are available now in beta for Pro and Max users in the U.S., while integrations with Apple Health and Android Health Connect are rolling out in beta for Pro and Max plan subscribers in the U.S. this week. Users must join a waitlist to access OpenAI’s ChatGPT Health tool.   The Bloomberg story has the usage information on Claude from nonprofit Banner Health: Banner Health, one of the largest nonprofit health systems in the US, has more than 22,000 clinical providers using Claude, and that 85% report working faster with higher accuracy. Anthropic is also working with customers such as Novo Nordisk A/S and Stanford Health Care.   All this activity highlights how important the healthcare sector is to the evolving AI service companies. — Read the full story from Bloomberg         The APAC region is one of the most complex global healthcare regions: diverse, tightly regulated, and changing faster than global playbooks can keep up. In Klick’s latest perspective, it explores how healthcare brands can balance global strategy with local relevance across Asia-Pacific. Discover how healthcare organizations are moving with greater speed, fluency, and confidence.   Read POV Now       Social Media 79% of marketers using paid social, 80%+ video Source: Meltwater Meltwater surveyed 1,500 marketers globally to see how they were approaching social media in 2026. Usage is high and still growing. Social, Especially Paid Social, More Important   This chart is a compilation of three from the Meltwater report. It includes these three questions: How is the role of social media developing? How is the role of paid social developing? Does your business run social media ads? (yes/no)   Chart created from data in Meltwater source   The exact same number of respondents said that social media and paid social are more important in 2026. This may seem repetitive but it shows the data is not a fluke. We thought maybe it was a typo but both questions total 100% so it looks legit. Carousels See Largest Growth   Video is the top post type for social media content, both organic and paid. This chart shows 2025 vs. 2026 and video is #1 in both years. We see that the carousel post type grew substantially in 2026 in spite of the fact that it's excluded from Meta's placement asset customization (PAC) tool. Image adapted for email from Meltwater source   1-4 Posts Per Week Most Common   This chart is two-in-one. It shows how often marketers post on different platforms but it's absolute values so it also shows what percent of the respondents use each platform. LinkedIn made a strong showing, indicating that there are many company brand marketers in the respondent mix. Image adapted for email from Meltwater source   Meltwater has three reports available: Global, The Americas, and EMEA. If you're marketing on social these reports have some broad data (biopharma was only a sliver of the respondents). — Read the full story from Meltwater         Traditional TV Pharma spends on TV - correlation with scripts Source: The VAB The Video Advertising Bureau (The VAB) had a top-10 deck for charts in 2025. Included was a chart of 17 pharma brands and their combined TV spend. The slide attributes brand sales to TV spend, which is correlated... but... correlation is not causation. Having said that, spend did accelerate when results were shown so that is a positive indicator. Chart created from data in VAB source   Don't interpret the lines crossing as important, the scales are different. — Read the full story from The VAB           Media Not all news is considered the same Source: DoubleVerify A report from later last year looked at how marketers feel about advertising next to news. Currently, 53% of advertisers use this content to advertise next to. Chart created from data in Double Verify source   Marketers also say this content is better for performance, 87% say the same or better than campaign averages. Chart created from data in Double Verify source   The types of news that are considered acceptable vary somewhat. This chart is a combined "very" or "somewhat" suitable and also "neither" suitable nor unsuitable. That last one is a bit of a stretch but if we interpret it as "meh" then presumably it fits. Image adapted for email from DoubleVerify source   Pharma is fairly high on the list of industries that are ok with advertising next to news. Looking at the industry ranking we're struck by the significance of each. For example if the power goes out, that's significant. Chart created from data in Double Verify source   — Read the full story from DoubleVerify         The Gifts We Remember are the Ones We Share.             For more than 15 years, Klick and the Legacy+ Foundation have partnered with Baraka Hospital to expand access to care in Kenya’s Mara region. Our latest holiday video, Many Hands, follows the ripple effect of that work—1,600 surgeries this year alone—told through the voices of the patients and medical teams who lead this effort every day.   Watch Many Hands Now       Regulatory Quality studies are the key to avoiding OPDP letters Source: MM+M This story from MM+M covers three different issues pharma faces in 2026 but the last one stands out for brand managers looking to thread the needle on OPDP expectations. This quote from Lucy Rose, a pharmaceutical consultant who previously served as director of the FDA’s DDMAC, now known as OPDP, sums it up: Marketers should be aware that the FDA is exceedingly concerned about having high quality data to support a claim in marketing materials, Rose said, such as pre-specified endpoints. Even in letters predating 2025, the FDA has pointed out that “just because you disclose study design deficiencies in the materials doesn’t mean it’s okay to use a poorly designed study to support a claim,” she explains.   So pay extra attention to your source studies when making claims to avoid the OPDP's ire in 2026 (and always -Ed.). — Read the full story from MM+M         HCP Omnichannel EU HCP priorities redux Source: Precision AQ We don't often do this, but we're reviving a report from Precision AQ from October that looks at EU biopharma and its priorities for HCPs (first reported in Klick Wire Issue 685). The company's chart-of-the-month for January is a reprise of its comparison between HCP-preferred channels and marketing-preferred ones. Image adapted for email from Precision AQ source   Here, the overvalued channels aren't really that overvalued since HCPs still position those in-person contacts as important. The undervalued channels, however, show a potential gap in how firms are reaching out to their HCP audience. This report is based on a survey of 216 pharma / biotech marketers across 10 European countries. If that's on your radar it's still fresh enough to be relevant in H1 2026. — Read the full story from Precision AQ         Regulation of AI 10 principles for responsible AI development in health Source: FDA The FDA and EMA have issued a two-page joint statement on regulating AI "for the safe and responsible use of artificial intelligence in developing medicines." A statement, reported in Reuters, from European Commissioner for Health and Animal Welfare Oliver Varhelyi highlights how AI is a focus on both sides of the Atlantic.  "The guiding principles of good AI practice in drug development are a first step of a renewed EU-US cooperation... to preserve our leading role in the global innovation race, while ensuring the highest level of patient safety."   The 10 principles can be summarized as: Human-centric by design Take a risk-based approach Must adhere to standards (legal, ethical, good practice) Limit the AI to a well-defined context of use Teams must have multidisciplinary expertise Exhibit good data governance and documentation Have sound model design and development with explainability Risk-based performance assessment Life cycle management with periodic re-evaluation Use clear, plain language to regulators and patients about the AI   — Read the full story from FDA         Traditional TV Small increase in TV year-over-year Source: FiercePharma Fierce reported on iSpot.tv's pharma leaderboard for December, 2025 which closed out the quarter and got an updated chart. It shows that our pixel-peep update was "iSpot-on" (just because you're a dad doesn't give you permission -Ed.). The new chart shows that there was a small lift from last year. As a reminder, this is the total of the top 10 brands on TV. Image adapted for email from FiercePharma source   Head over to Fierce to get the full brand list. — Read the full story from FiercePharma         mHealth Top 10 CES health devices Source: PCMag The Consumer Electronics Show was two weeks ago and here are some of the top health tech products being introduced. Peri: a wearable perimenopause device that tracks anxiety, hot flashes, menstrual changes, night sweats, and sleep disturbances. The companion app suggests treatments including pharmaceuticals. Tombot Jennie: a robot emotional support puppy designed for seniors with dementia, but adored by all. Allergen Alert: a portable tester for common allergens such as eggs, fish, gluten, milk, peanuts, sesame, shellfish, soy, tree nuts, and wheat. Dephy Sidekick: exoskeleton shoes with removable robotic calf muscles that strap around your legs. Smart Hip Guardian: airbags for falls to reduce hip fractures. The single-use products come in two-packs. SunBooster: a device that fits on your monitor that emits near-infrared (NIR) light, offering similar health benefits as natural sunlight, but indoors. Petal SmartBra: measures body mass index (BMI), breathing, heart rate, heart rate variability (HRV, an indicator of stress). Sensate: is a non-invasive vagus nerve stimulation device that creates gentle, soothing vibrations to reduce anxiety and stress. Tonino Lamborghini SuperBrain Edition: a soft headband that helps the wearer train their brain to focus or relax on command. L’Oréal LED Face Mask: an electronic mask that delivers targeted red and NIR light to target fine lines, sagging, and uneven tone.   — Read the full story from PCMag         GenAI Search Advertisers want ethics applied to agentic Source: eMarketer The Association of National Advertisers (ANA) surveyed marketers about agentic commerce. The top action marketers want is for others to ensure ethics in the models. The actions that brands can take include optimizing content, making patient-first plans, and presenting brand data in machine-readable formats. Image adapted for email from eMarketer source   — Read the full story from eMarketer         Regulatory Roundup Stories from and about the FDA SOPP 8217: Administrative Processing and Review Management Procedures for Investigational New Drug Applications -- Jan 14     Two new untitled letters, one for a website and one for a TV ad     Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products -- draft guidance     Request for Patient and Consumer Advocacy Group Participation in BsUFA Reauthorization Stakeholder Consultation Meetings               Klick Ideas Exchange   — idx.klick.com     Have you explored IDX yet?   Featuring a wide selection of the most relevant videos, original interviews, articles, and POVs, Klick Ideas Exchange (IDX) provides industry leaders with tailored insights to support innovative and exponential thinking. Sign up or log in today and explore all the new features.   — Browse all ideas                Klick Health, 240 W 40th St, 12th Floor, New York  NY, 10018  USA  You are receiving this email because you subscribed to our mailing list. Want to change how you receive these emails? Unsubscribe     © 2026 All rights reserved. Klick Health® is a trademark of Klick Inc. Privacy Policy |
| --- |